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Edited by Giulio Superti-Fu¨rgaAbstract Reversible protein-phosphorylation is emerging as a
key player in the regulation of mitochondrial functions. In par-
ticular tyrosine phosphorylation represents a promising ﬁeld to
highlight new mechanisms of bioenergetic regulation.
Utilizing immunoaﬃnity enrichment of phosphotyrosine-con-
taining peptides coupled to mass spectrometric analysis we de-
tected new tyrosine phosphorylated proteins in rat brain
mitochondria after peroxovanadate treatment. By bioinformatic
predictions we provide suggestions about the potential role of
tyrosine phosphorylation in mitochondrial physiology. Our re-
sults indicate a primary role of tyrosine phosphorylation in reg-
ulating energy production at the mitochondrial level. Moreover,
tyrosine phosphorylation might regulate the mitochondrial mem-
brane permeability targeting protein complexes containing ADP/
ATP translocase, VDAC, creatine kinase and hexokinase.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Reversible protein-phosphorylation is emerging as a key
player in the regulation of mitochondrial functions. First
drafts of a mitochondrial Ser/Thr phosphoproteome have been
recently published [1,2], highlighting a role of reversible phos-
phorylation in diﬀerent mitochondrial processes [3] and several
Ser/Thr kinases and phosphatases have been described in mito-
chondrial compartments [3]. Tyrosine phosphorylation is also
emerging as a central mechanism for regulating mitochondrial
functions, and the involvement of tyrosine phosphorylation in
mitochondrial signaling is discussed in depth in a recent review
[4]. To date, only tyrosine kinases belonging to the Src familyAbbreviations: ANT, ADP/ATP translocase; COX, cytochrome c
oxidase; mtCK, mitochondrial creatine kinase; ETC, electron-trans-
port chain; HK-I, Type I hexokinase; MPT, mitochondrial perme-
ability transition; PTPM-1, protein tyrosine phosphatase localized to
the mitochondrion 1; RBM, rat brain mitochondria; VDAC, voltage-
dependent anion channel
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doi:10.1016/j.febslet.2008.02.077have been described in mitochondrial compartments such as
Lyn, c-Src, Fyn and Fgr [5–8]. In this context, at least two dif-
ferent anchoring proteins, AKAP121 [7] and Dok-4 [8], regu-
late the association of c-Src with mitochondria. The
reversibility of phosphorylation is guaranteed by the presence
of tyrosine phosphatases: a pool of shp-2 has been described in
mitochondrial compartments [9] and more important, the
PTPM-1 (protein tyrosine phosphatase localized to the mito-
chondrion 1), has been discovered as the ﬁrst tyrosine phospha-
tase with an almost exclusive mitochondrial localization [10].
Tyrosine phosphorylation seems to have a primary role in reg-
ulating electron-transport chain (ETC) activity. Cytochrome c
oxidase (COX), the terminal respiratory complex of ETC, has
been identiﬁed as a substrate for the tyrosine kinase c-Src [6].
C-Src phosphorylates COX subunit II in vitro and in osteo-
clasts at so far unidentiﬁed site/s; it thereby activates COX
and, in turn, increases the eﬃciency of the mitochondrial
ETC [6]. Tyrosine phosphorylation of COX subunit I on
Y304 by an unidentiﬁed kinase and upon activation of the
cAMP-dependent pathway, leads to opposing eﬀects on the
activity of the enzyme [11]. Increased targeting of c-Src to mito-
chondria by AKAP121 enhances mitochondrial membrane po-
tential and ATP oxidative synthesis in a c-Src dependent
manner [7]. Overexpression of Dok-4 is associated with a de-
crease of the expression of Complex I, strictly dependent to
the activity of the c-Src kinase activity, modulating also the
subsequent production of reactive oxygen species [8].
A reduction in mitochondrial tyrosine phosphoprotein pro-
ﬁle by the knock-down of PTPM-1 in pancreatic insulinoma
cell line INS-1 markedly enhances ATP production at the
mitochondrial level [10].
Recently, new tyrosine phosphorylated mitochondrial pro-
teins and their phosphorylation sites have been identiﬁed by
mass proteomic approaches (see below), but the deﬁnition of
a complete mitochondrial tyrosine phosphoproteome is only
at the very beginning. Utilizing the KESTREL approach, we
have previously identiﬁed the ﬂavoprotein of succinate dehy-
drogenase and aconitase as in vitro mitochondrial substrates
of Fgr by identiﬁcation of the respective phosphorylation sites
[12].
Here we identify new tyrosine phosphorylated proteins in rat
brain mitochondria after peroxovanadate treatment by immu-
noaﬃnity enrichment of phosphotyrosine-containing peptides
coupled to mass spectrometry analysis. We also provide infor-
mation regarding the potential role of tyrosine phosphoryla-blished by Elsevier B.V. All rights reserved.
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bioinformatic tools.2. Materials and methods
2.1. Isolation and puriﬁcation of rat brain mitochondria
Rat brain mitochondria (RBM) were isolated by diﬀerential centri-
fugation and puriﬁed by the Ficoll gradient method as described in
Supplementary methods online.
2.2. RBM incubation
RBM (20 mg) were resuspended in 1 ml buﬀer containing 200 mM
sucrose, 50 mM HEPES, 0.5 mM EDTA, pH 7.4. At t0 1 mM peroxo-
vanadate, 1 mM MnCl2, 1 mM ATP and 1 lg/ml olygomycin was
added and the sample was incubated for 20 min at 30 C. The reaction
was stopped by centrifugation for 10 min at 12000 · g. The assessment
of mitochondrial integrity during peroxovanadate treatment was tested
in a control experiment without olygomycin as described in Supple-
mentary methods online.
2.3. Additional methods
Methods for mitochondrial lysis, digestion, phosphopeptide isola-
tion and puriﬁcation as well as mass spectrometric analysis are avail-
able in Supplementary methods online.3. Results and discussion
In order to identify novel tyrosine phosphorylated mito-
chondrial proteins we utilized a targeted proteomic approach
combined with the immunoaﬃnity enrichment of phosphoty-
rosine-containing peptides. Mitochondria were isolated from
rat brain because a previous tyrosine kinase assay on the gen-
eric tyrosine kinase substrate PolyGlu Tyr(4:1), has demon-
strated a much higher tyrosine kinase activity in brain
mitochondria than in mitochondria puriﬁed from rat liver
and heart [12], thus resulting in a higher probability to identify
tyrosine phosphorylated mitochondrial proteins. Isolated
mitochondria were puriﬁed by a Ficoll gradient ensuring a
high degree of purity (see Supplementary methods online).
Tyrosine phosphorylation is generally switched oﬀ under nor-
mal conditions, ascribable to the high activity of tyrosine phos-
phatases and to the general inactivation state of the tyrosineFig. 1. (A) Anti-phosphotyrosine Western blotting of untreated control and p
were subjected to SDS–PAGE followed by Western Blotting on PVDF mem
Base peak chromatograms of (a) enhanced multiple charge scans and (b) pre
The complexity of the sample mixture is clearly decreased by using a distinct
216. This enables the detection, fragmentation and identiﬁcation even of low
presence of other peptide ion signals and thus not detected in common survkinases in the absence of an appropriate signal [13]. Therefore,
we treated RBM for 20 min at 30 C with 1 mM peroxovana-
date, a potent and generic tyrosine phosphatase inhibitor [14],
to enhance the presentation of tyrosine phosphorylated pro-
teins. The integrity of mitochondrial membranes during this
treatment is mandatory to reduce the risk of introducing arti-
facts because of the peroxovanadate treatment. As reported in
Supplementary methods, mitochondrial membrane potential
and the respiratory control ratio do not change after the incu-
bation. Moreover, we detected no cytochrome c by Western
blotting in the supernatant after the treatment conﬁrming the
integrity of mitochondrial membranes (see Supplementary
methods). Mitochondria were pelleted, lysed and tryptically di-
gested. The phosphopeptides were then aﬃnity captured using
a mixture of 4G10 (Upstate Biotechnology) and PY20 (ICN)
anti-phosphotyrosine antibodies. The extent of phosphoryla-
tion for untreated and treated samples was detected by anti-
phosphotyrosine Western blotting as shown in Fig. 1A. Phos-
phopeptides were then analyzed by mass spectrometry. Ini-
tially, an enhanced multiple charge scan was used scanning
primarily for doubly and triply charged ions. Despite detection
of several phosphotyrosine-containing peptides, the majority
of detected peptides were attributed to high abundant, non-
phosphorylated peptides of mitochondrial proteins such as
ATP synthase alpha/beta chain or malate dehydrogenase. By
this approach seven phosphorylation sites were identiﬁed. To
further improve this number, we used a precursor ion scan
technique for the phosphotyrosine-immonium ion at m/z 216.
This scan type exhibits some cross-talk to dipeptide ions at
m/z 216 derived, e.g. from Asn-Thr, Gln-Ser or Lys-Ser. Nev-
ertheless, the number of fragmented peptide signals was mainly
limited to peptides containing the respective marker ion while
omitting non-phosphorylated peptides still present after the
aﬃnity puriﬁcation as background (compare Fig. 1B). This
markedly increased the number of identiﬁed phosphopeptides
and phosphorylation sites form 7 to 15, while covering all
but one (Q62950 dihydropyrimidinase-related protein 1) of
the sites initially detected without precursor ion scanning.
High conﬁdence in the identiﬁcations is based on four facts:
(1) using a Mascot score cutoﬀ for database search results of
>35 equals to >99.5% probability for a true positive identiﬁca-
tion. (2) Searches against a concatenated Swiss-Prot decoyeroxovanadate-treated RBM. Control (40 lg) (a) and treated RBM (b)
brane and immunostaining with anti-phosphotyrosine antibody. (B)
cursor ion scans for the analysis of aﬃnity enriched phosphopeptides.
selection criterion such as the phosphotyrosine-immonium ion at m/z
abundant phosphopeptides, whose signals are usually quenched in the
ey scans such as (a).
Table 1
Tyrosine phosphorylated peptides of proteins constitutively associated with mitochondria identiﬁed in this paper
GenBank accession number Name Peptide Sub-mitochondrial localization
Q05962 ADP/ATP translocase 1 RAAYFGV#YDTAKG Inner membrane
Q09073 ADP/ATP translocase 2 RAA#YFGIYDTAKG
RAAYFGI#YDTAKG
Inner membrane
P05708 Hexokinase-1 KGAAMVTAVA#YRL Outer membrane facing cytosol
P27881 Hexokinase-2
P35571 Glycerol-3-phosphate dehydrogenase,
mitochondrial precursor
RFLY#YEMGYKS Inner membrane
P25809 Creatine kinase, ubiquitous mitochondrial
precursor
RSG#YFDERY Intermembrane space
P29419 ATP synthase e chain, mitochondrial RYS#YLKPRA Inner membrane
All the identiﬁed phosphopeptides together with the corresponding mass spectra are attached as Supplementary material.
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sitive hits using the previous search parameters. (3) In addition
to the phosphotyrosine-speciﬁc immunoprecipitation of pep-
tides, all but one of the phosphorylation sites were identiﬁed
by precursor ion scans for the phosphotyrosine-immonium
ion at m/z 216. (4) All spectra used for reported identiﬁcations
were manually veriﬁed and checked for criteria such as coher-
ent ion series and accurate assignment of phosphorylation
sites.
Identiﬁed phosphopeptides of proteins constitutively associ-
ated with mitochondria are reported in Table 1 by accession,
sequence and proposed sub-mitochondrial localization. All
the identiﬁed phosphopeptides are reported in Supplementary
Table 1 together with detailed information such as mass devi-
ance and Mascot scores. In addition, annotated spectra as pre-
sented by Mascot can be found within the supplement.
To our best knowledge, the phosphorylation sites identiﬁed
in these mitochondrial proteins have not been annotated previ-
ously, with exception of the two sites of ADP/ATP translocase
(ANT) which were very recently identiﬁed also by Villen and
colleagues in mouse liver by a large scale analysis strategy
[15]. The identiﬁcation of these novel tyrosine phosphorylated
proteins conﬁrm other experimental evidences [6–8,10] show-
ing that tyrosine phosphorylation is strongly involved in the
regulation of energy production at the mitochondrial level.
In this regard, the mitochondrial glycerol-3-phosphate dehy-
drogenase is an essential component of the glycerol phosphate
shuttle which transfers cytosolic reducing equivalents, gener-
ated mainly during glycolysis, to the mitochondrial electron-
transport chain. The mitochondrial e subunit of ATP-synthase
is one of the chains of the non-enzymatic component (the
membrane proton channel) of the complex which catalyses
the synthesis of ATP driven by the proton motive force across
the inner mitochondrial membrane. Three of the proteins here
identiﬁed as tyrosine phosphorylated (hexokinase, creatine ki-
nase and ADP/ATP translocase) together with voltage-depen-
dent anion channel (VDAC) (also subjected to tyrosine
phosphorylation [16]), belong to the same molecular com-
plexes responsible for the formation of mitochondrial contact
sites [17]. In the ﬁrst complex VDAC and ANT interact di-
rectly thus providing VDAC with higher aﬃnity for hexoki-
nase, while in a second complex VDAC interacts indirectly
with ANT through a mitochondrial creatine kinase octamer.
In this case VDAC apparently exposes a diﬀerent structural
motif at the cytosolic side that provides lower aﬃnity for hexo-
kinase [17]. Contact sites are dynamic structures since their fre-
quency depends on the metabolic activity of the cell but themechanisms of regulation are still unknown [18]. Moreover,
all of these four proteins have been recognized as potential
structural or regulatory components of the so called ‘‘mito-
chondrial permeability transition’’ (MPT) pore, whose opening
is involved in cell energy collapse and induction of cell death
(for a recent review see Ref. [19]).
As the crystal structures of these proteins have been solved,
we utilized in silico models to investigate potential roles of
tyrosine phosphorylation.
The ANT is the most abundant mitochondrial carrier; it is
essential to import ADP into the mitochondrial matrix and
to export the regenerated ATP towards the cytosol. Bovine
ANT has been co-crystallized in complex with the inhibitor
carboxyatractyloside [20]. Six a-helices (H1–H6) form a trans-
membrane domain while the backbone of the ADP/ATP car-
rier mimics the form of a basket; it is mainly hydrophilic,
closed toward the matrix and opened widely toward the inner
membrane. The transport substrates bind to the bottom of the
cavity and the translocation results from a transient transition
from a pit to a channel conformation [20]. Fig. 2A shows the
structure of ANT, where the two identiﬁed phosphorylated
tyrosines (Y190 and Y194) are indicated. The ﬁrst important
observation is that both tyrosines are located inside the cavity.
This position already suggests that tyrosine phosphorylation
could be involved in the regulation of the transport. Panel B
of Fig. 2 reports the electrostatic surface of the protein before
and after the phosphorylation. Before phosphorylation the
internal surface of the cavity is positively charged (the nucleo-
tides transported are negatively charged). In contrast, the
phosphorylation of Y190 or Y194 clearly changes the electro-
static surface of the cavity (Fig. 2B).
Moreover, aromatic residues are not uniformly distributed
within the cavity but are grouped along H4. Y194 is the ﬁrst
of three highly conserved tyrosines, Y194/Y190/Y186, with
side chains oriented towards the cavity; this arrangement
forms a ladder along H4, entering the cavity (see Fig. 2C). It
has been suggested that a stacking interaction with tyrosine
rings could guide the ADP translocation along the tyrosine
ladder [20]. Double mutation of Y203 and Y207 in yeast
(equivalent to Y186 and Y190 in the bovine carrier) prevented
or slightly reduced cellular growth on a non-fermentable car-
bon source when mutated into alanines or phenylalanines,
respectively [20]. These observations strongly support the
hypothesis that the tyrosine phosphorylation of Y190 and
Y194 could alter the rate and/or the speciﬁcity of the transport.
Moreover, it was reported that ANT can be switched between
anti-porter state, speciﬁc for substrate exchange (ATP/ADP),
Fig. 2. Structure of ADP/ATP translocase (Protein Data Bank entry 1ock, bovine ANT). (A) Surface representation of ANT where the two tyrosines
identiﬁed as phosphorylated are marked in black sticks. Also the ADP/ATP inhibitor carboxyatractyloside is black. (B) Electrostatic surface before
and after addition of phosphate groups to Y194 or Y190. The phosphate group has been added utilizing Insight II Software Inc. (Accelrys Inc., San
Diego), minimized using the Discover module until the energy reached a minimum, and electrostatic surface has been calculated with APBS
(Adaptive Poisson–Boltzmann Solver, see [28]). Positive and negative surfaces are shown in blue and red, respectively. (C) Cartoon model where the
tyrosine ladder (black sticks) is shown. Carboxyatractiloside is marked in black. The images were generated with PyMol Software (DeLano, W.L.
The PyMOL Molecular Graphics System, 2002, http://www.pymol.org).
Fig. 3. (A) Overview of hexokinase structure (Protein Data Bank entry 1cza, human hexokinase I). Tyrosine residue identiﬁed as phosphorylated
(Y461) is marked in black and indicated by an arrow. Two molecules of G-6-P, in black, are in the two catalytic sites, shown by arrows. The N-
terminus (N) and the C-terminus (C) are shown. (B) In silico model of eﬀects of Y461 phosphorylation on protein structure. The structures with (in
white) and without (in black) phosphate added to the tyrosine are superimposed. The phosphate has been added utilizing Insight II Software Inc.
(Accelrys Inc., San Diego) and minimized using the Discover module until the energy reached a minimum. The images were generated with PyMol
Software (DeLano, W.L. The PyMOL Molecular Graphics System, 2002, http://www.pymol.org).
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can be assigned for permeability transition [21]; tyrosine phos-
phorylation could well be involved in this process. Although
several experimental evidences have been accumulating thatdiﬀerent proteins or protein complexes are responsible of mito-
chondrial membrane permeabilization [21,22], ANT is still
considered the major component of the ‘‘classical’’ MPT pore
[21].
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ters alternative metabolic pathways. Nonetheless hexokinase is
most commonly thought of as a glycolytic enzyme and glyco-
lytic metabolism in turn is considered to be a cytoplasmic pro-
cess. However, this enzyme was found predominantly
associated with mitochondria and, more speciﬁcally with the
outer membrane. The stacked assembly of translocase, porin
and hexokinase permits the direct exchange of adenine nucle-
otides between the mitochondrial matrix and the hexokinase
active site. Type I hexokinase (HK-I) constitutes the predom-
inant form of the enzyme in brain [23]. It consists of two halves
which show about 30% sequence identity between the N- and
C-terminal halves, however, only the C-terminal half is catalyt-
ically active, while the N-terminal is not [23]. Glucose-6-phos-
phate is a potent inhibitor of hexokinase I and it could bind to
both halves. The binding of G6P to either N-terminal half
(allosteric inhibition) or the C-terminal half (direct inhibition)
of the enzyme inhibits catalysis. Pi reliefs this inhibition by
exclusively associating with high aﬃnity to the inactive N-ter-
minal half. Binding of the eﬀectors at the N-terminal halfFig. 4. Mitochondrial creatine kinase ribbon model (Protein Data Bank entry
mt-CK are shown. Identiﬁed phosphotyrosine residues are shown as white sp
The PyMOL Molecular Graphics System, 2002, http://www.pymol.org).
Table 2
All tyrosine phosphorylated mitochondrial proteins previously identiﬁed
Name Sub-mitochond
Cytochrome c oxidase Inner membran
Cytochrome c Inner membran
(facing interme
Malate dehydrogenase Matrix
Succinate CoA-ligase Matrix
Long chain acyl CoA synthetase 1 Outer membra
VDAC-2 Outer membra
3-Ketoacyl-CoA-thiolase Matrix
Pyruvate dehydrogenase E1 component a subunit Matrix
Carbamoyl-phosphate synthase Matrix
Glutamate dehydrogenase 1 Matrix
Aspartate aminotransferase Matrix
ATP synthase O subunit Inner membran
Ubiquinol–cytochrome-c reductase complex core protein 2 Inner membran
Isoform mitochondrial of fumarate hydratase Matrixdetermines two diﬀerent conformations of the C-term half,
one permits the association of ATP and the other antagonizes
ATP binding. These conformational changes are transmitted
from the N-terminal to the C-terminal half by a rotation of
6 of the helix that connects the two halves inﬂuencing the po-
sition of a loop near the catalytic site [24]. Fig. 3A depicts the
structure of human HK-I. The tyrosine identiﬁed as phosphor-
ylated (in black) is localized in the helix that connects the two
halves. The position of this tyrosine suggests a potential
involvement of this post-translational modiﬁcation in the allo-
steric regulation of the catalytic activity of the enzyme. This
possibility has been investigated in an in silico model. Analyz-
ing the amino acids close to the identiﬁed tyrosine (Y461), we
ﬁnd K147 and E465, too. We therefore generated a model add-
ing a phosphate group to the tyrosine and minimizing the en-
ergy. As can be seen in Fig. 3B, after the addition of phosphate
(white sticks) the lysine approaches the added phosphate while
the glutamic is turned away to the opposite direction because
of the electrostatic repulsion. These electrostatic interactions
may be responsible for a conformational change of the con-1qk1, human mt-CK). Two diﬀerent orientations of octameric form of
heres. The images were generated with PyMol Software (DeLano, W.L.
rial localization Function References
e ETC [11]
e
mbrane space)
ETC [29]
Krebs cycle [30]
[15]
Krebs cycle [30]
ne Fatty acids transport [16]
ne Outer membrane permeability [16]
Fatty acid b-oxidation cycle [15]
Pyruvate degradation [15]
Urea cycle [15]
Nitrogen and glutamate metabolism [15]
Transamination [15]
e ATP synthesis [15]
e ETC [15]
Krebs cycle [16]
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transmitted to the catalytic site thereby modulating its activity.
It is interesting to remember that ligands of hexokinase can
also regulate the MPT-like structures, since VDAC as part
of the complex can transmit structural changes of hexokinase
to the ANT [25].
Mitochondrial creatine kinase (mtCK) together with its
cytosolic form is a central controller of cellular energy homeo-
stasis creating a large pool of rapidly diﬀusing phosphocreatine
for temporal and spatial buﬀering of ATP levels (for a review
see [26]). MtCK, localized in the intermembrane space of mito-
chondria, occurs in two diﬀerent oligomeric forms: dimers and
octamers. The octameric form has a fourfold symmetry with
dimers arranged along the symmetry axis. Top and bottom
faces of the octamer are identical and confer the ‘‘sticky’’ char-
acter to the protein which is responsible for binding to nega-
tively charged surfaces [27]. A speciﬁc, direct protein–protein
interaction of electrostatic nature between mtCK and VDAC
has been demonstrated. The direct interaction partner would
be cardiolipin in the inner membrane. The high aﬃnity of
mtCK and ANT for cardiolipin would allow for close co-local-
ization of both proteins in cardiolipin membrane patches [26].
Fig. 4 depicts the octameric structure of the human mtCK in
two diﬀerent orientations. The phosphorylated tyrosine identi-
ﬁed in this study is indicated in each monomer. These tyrosines
are located far from the catalytic site and moreover they are
not in proximity of the overlapping regions among the mono-
mers; however, as shown in Fig. 4, these tyrosines are located
on the top and bottom of the octamer suggesting that the
phosphorylation could regulate membrane association. Sup-
porting this hypothesis, two sequences stretches have been
identiﬁed which are properly exposed at the top and bottom
faces of the octamer, carrying a positive net charge [27]. They
encompass the C-terminus (Asp357-His379) and a short inter-
nal stretch (Ala108-Y115) [27]. The identiﬁed tyrosine is the
terminal residue of the second stretch. The addition of a neg-
atively-charged phosphate group may therefore destabilize
the association of mtCK with the outer and/or inner mem-
brane.
Finally, Table 2 reports all tyrosine phosphorylated mito-
chondrial proteins published up to date. Table 2 together with
Table 1 represents the ﬁrst draft of a mitochondrial tyrosine
phosphoproteome. It is important to highlight that phosphor-
ylated proteins are distributed to all mitochondrial compart-
ments and that this post-translational modiﬁcation may be
involved in almost all mitochondrial functions from ETC,
Krebs cycle, fatty acids b-oxidation cycle, urea cycle, metabo-
lite transports, etc.
This ﬁrst draft permits us to suggest, as already reported [4],
that tyrosine phosphorylation could indeed represent a new
frontier in mitochondrial signaling.
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